JHOP Articles

Skip to main content

Patient Management With ADCETRIS™: An Advanced Practice Oncology Nurse Roundtable Discussion

Ellen Neylon, RN, BSN, CCPR, OCN, Stephanie Thompson, NP-C, MSN, RN, Amanda Copeland, MSN, RN, CNS

Brother, Can You Spare Some Chemotherapy? No End in Sight for Drug Shortages

Timothy G. Tyler, PharmD, FCSHP, FHOPA

Original Research

Ifosfamide Neurotoxicity in Pediatric Patients: A Multi-Institutional Case Series Report

Amy Lee, MD, David W. Henry, MS, RPh, BCOP, FASHP, John Szechung Ng, PharmD, Kerry Parsons, PharmD, BCOP, Betsy Bickert Poon, PharmD, FCCP, Jeff Schwartz, MD, Tara Smith, PharmD, Chatchawin Assanasen, MD

Perspective

Dosing Chemotherapy in Obese Patients: No Clear Answers, Yet

Scott Soefje, PharmD, BCOP

From the Literature

Concise Reviews from the Literature Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Original Research

Carboplatin Dosing in Overweight and Obese Patients: A Single-Center Experience

Ginah Nightingale, PharmD BCOP, James A. Trovato, PharmD, MBA, BCOP, FASHP, Myounghee Lee, PhD, PharmD, Jennifer Thompson, PharmD, BCOP

Perspective

Ipilimumab: A New Era in Metastatic Melanoma Management

Timothy G. Tyler, PharmD, FCSHP, FHOPA

FDA Updates

Reversible Posterior Leukoencephalopathy Syndrome Secondary to Bevacizumab

Diana Pinto, PharmD, William Kernan, PharmD, BCPS, James Hoffman, MD, Mohammed Ibrahim, PharmD, CRPH, BCOP, BCPS, Bruno Bastos, MD

Original Research

The Risk of Neurotoxicity with Concomitant Use of Aprepitant and Ifosfamide

Anthony Jarkowski III, PharmD, BCOP, Austin Miller, PhD, Tammy A. Hecke, RN, BSN, Leona Blustein, PharmD, Michael K.K. Wong, MD, PhD, FRCPC

Practical Issues in Pharmacy Management

Implementation of a Pharmacist-Managed Interdisciplinary Oral Chemotherapy Program in a Community Cancer Center

Robert Mancini, PharmD, BCOP, FHOPA, Lindsay M. Kaster, PharmD, Brian Vu, PharmD, Jessie Modlin, PharmD, David B. Wilson, RPh

Page 194 of 200
Results 1931 - 1940 of 1993